Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C7H11N3O6S |
Molecular Weight | 265.244 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)[C@@H]1CC[C@@H]2C[N@]1C(=O)N2OS(O)(=O)=O
InChI
InChIKey=NDCUAPJVLWFHHB-UHNVWZDZSA-N
InChI=1S/C7H11N3O6S/c8-6(11)5-2-1-4-3-9(5)7(12)10(4)16-17(13,14)15/h4-5H,1-3H2,(H2,8,11)(H,13,14,15)/t4-,5+/m1/s1
Molecular Formula | C7H11N3O6S |
Molecular Weight | 265.244 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 20:13:18 UTC 2023
by
admin
on
Fri Dec 15 20:13:18 UTC 2023
|
Record UNII |
7352665165
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175930
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB09060
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
CHEMBL1689063
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
Ceftazidime and Avibactam
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
Avibactam
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
8972
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
SUB72111
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
7352665165
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
9835049
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
1192500-31-4
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
DTXSID901026066
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
C171777
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
100000135830
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
1603834
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | RxNorm | ||
|
7352665165
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | |||
|
m2148
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
4946
Created by
admin on Fri Dec 15 20:13:18 UTC 2023 , Edited by admin on Fri Dec 15 20:13:18 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
EXCRETED UNCHANGED |
An average of 85% of administered avibactam was recovered from the urine as unchanged drug within 96 hours
URINE
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
RACEMATE -> ENANTIOMER |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
URINE
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
MULTIPLE DOSE ADMINISTRATION |
|
||
Biological Half-life | PHARMACOKINETIC |
|
SINGLE DOSE ADMINISTRATION |
|
||